Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabesity Research
Volume 4, Issue 1, Pages 45-57
http://dx.doi.org/10.1080/15438600303729

Des(1–3)IGF-1 Treatment Normalizes Type 1 IGF Receptor and Phospho-Akt (Thr 308) Immunoreactivity in Predegenerative Retina of Diabetic Rats

1University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
2Colorado State University, Fort Collins, Colorado, USA
3Department of Ophthalmology, Physiology and Biophysics, University at Buffalo, the State University of New York, 3435 Main Street, Sherman 124, Buffalo, NY 14214, USA

Received 4 October 2002; Accepted 2 February 2003

Copyright © 2003 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

A. Kummer, B. E. Pulford, D. N. Ishii, and G. M. Seigel, “Des(1–3)IGF-1 Treatment Normalizes Type 1 IGF Receptor and Phospho-Akt (Thr 308) Immunoreactivity in Predegenerative Retina of Diabetic Rats,” Experimental Diabesity Research, vol. 4, no. 1, pp. 45-57, 2003. https://doi.org/10.1080/15438600303729.